170 related articles for article (PubMed ID: 38333222)
1. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
Qiao W; Li J; Wang Q; Jin R; Zhang H
J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
[TBL] [Abstract][Full Text] [Related]
3. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
Qiao W; Li J; Xiong Y; Zheng J; Jin R; Hu C
J Cancer Res Clin Oncol; 2024 May; 150(5):241. PubMed ID: 38713414
[TBL] [Abstract][Full Text] [Related]
4. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
Qiao W; Xiong Y; Li K; Jin R; Zhang Y
J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
[TBL] [Abstract][Full Text] [Related]
5. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
Zhang H; Sheng S; Qiao W; Sun Y; Jin R
Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
[TBL] [Abstract][Full Text] [Related]
7. External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy.
Qiao W; Wang Q; Mei T; Wang Q; Wang W; Zhang Y
Front Surg; 2023; 10():1045213. PubMed ID: 36936655
[TBL] [Abstract][Full Text] [Related]
8. A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy.
Zhang H; Sheng S; Qiao W; Han M; Jin R
Front Oncol; 2024; 14():1340286. PubMed ID: 38384805
[TBL] [Abstract][Full Text] [Related]
9. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
10. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation.
Qiao W; Fan Z; Wang Q; Jin R; Hu C
J Hepatocell Carcinoma; 2024; 11():65-79. PubMed ID: 38235069
[TBL] [Abstract][Full Text] [Related]
12. The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages.
Nagahara T; Sugihara T; Kihara T; Ikeda S; Hoshino Y; Matsuki Y; Sakaguchi T; Kurumi H; Onoyama T; Takata T; Matono T; Yamaguchi N; Isomoto H
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672339
[TBL] [Abstract][Full Text] [Related]
13. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
14. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
[No Abstract] [Full Text] [Related]
15. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
16. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
17. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
18. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
19. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
20. A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.
Li W; Han L; Xiao B; Li X; Ye Z
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
